Why IMU is a multi multi bagger, page-29

Clearly you don’t understand this company and probably don’t understand biotech stocks. The company has never claimed this to be a cure. They don’t expect any single treatment to be a cure. They are confident that a combination therapy of two perpendicular treatments will give a considerable extension of life for most people. As treatments progress there will be more choices and it will be better targeted.

What IMU is doing is building a company with 4 next generation platform technologies that will advance this aim considerably.

In the case of Hervaxx they have found a way to program the body to produce its own antibodies using the B Cell immune system allowing IMU to bypass the patent protection that cover immune drugs with about $20bn dollars of annual sales. Further to that Hervaxx is far cheaper to produce bringing relief to a lot more people.

You might not be interested in IMU, but the two companies that are currently earning $20bn PA and risk losing that income will be.

There interest will drive the SP far higher than your interest ever would.